WallStreetZenWallStreetZen

NASDAQ: INKT
Mink Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

INKT past revenue growth

How has INKT's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
INKT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INKT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

INKT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$22.5M
Current Profit Margin
0%

INKT Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when INKT announces earnings.

INKT Return on Assets

Current Company
-220.6%
Current Industry
2.9%
INKT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INKT Return on Capital Employed

Current Company
327.84%
Current Industry
19.5%
INKT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INKT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INKT$0.00-$22.25M-$22.46M-100.00%N/A
CASI$33.88M-$22.29M-$26.96M+69.23%N/A
VIRX$0.00-$46.86M-$51.06M-100.00%N/A
ACXP$0.00-$14.58M-$14.58MN/AN/A
EVGN$5.64M-$20.34M-$23.88M+26.41%N/A
View Top Biotech Stocks

INKT earnings dates

Next earnings date
Jun 12, 2024

Mink Therapeutics Earnings & Revenue FAQ

What were INKT's earnings last quarter?

On Invalid Date, Mink Therapeutics (NASDAQ: INKT) reported Q4 2023 earnings per share (EPS) of -$0.15, up 34.78% year over year. Total Mink Therapeutics earnings for the quarter were -$5.46 million. In the same quarter last year, Mink Therapeutics's earnings per share (EPS) was -$0.23.

If you're new to stock investing, here's how to buy Mink Therapeutics stock.

What was INKT's earnings growth in the past year?

As of Q2 2024, Mink Therapeutics's earnings has grown year over year. Mink Therapeutics's earnings in the past year totalled -$22.46 million.

What is INKT's earnings date?

Mink Therapeutics's earnings date is Invalid Date. Add INKT to your watchlist to be reminded of INKT's next earnings announcement.

What was INKT's revenue last quarter?

On Invalid Date, Mink Therapeutics (NASDAQ: INKT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Mink Therapeutics's revenue was $0.00.

What was INKT's revenue growth in the past year?

As of Q2 2024, Mink Therapeutics's revenue has grown null year over year. Mink Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.